Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?

Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalReview article

27 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)153-156
Number of pages4
JournalInternational Journal of Neuropsychopharmacology
Volume8
Issue number2
DOIs
StatePublished - Jun 1 2005

Fingerprint

olanzapine
Dibenzothiazepines
Risperidone
Long-Term Care
Benzodiazepines
Antipsychotic Agents
Schizophrenia
Quetiapine Fumarate

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{f7d66741b9304c1b972e318f0622ea54,
title = "Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?",
author = "Meltzer, {Herbert Y.}",
year = "2005",
month = "6",
day = "1",
doi = "10.1017/S1461145705005183",
language = "English (US)",
volume = "8",
pages = "153--156",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "2",

}

TY - JOUR

T1 - Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone

T2 - Are there differences?

AU - Meltzer, Herbert Y.

PY - 2005/6/1

Y1 - 2005/6/1

UR - http://www.scopus.com/inward/record.url?scp=20044382698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044382698&partnerID=8YFLogxK

U2 - 10.1017/S1461145705005183

DO - 10.1017/S1461145705005183

M3 - Review article

C2 - 15780147

AN - SCOPUS:20044382698

VL - 8

SP - 153

EP - 156

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 2

ER -